## 3 Results  
Table 1 presents the muscle oxygenation data for the three measurement points. The post hoc analysis showed significant differences in the final occlusion between points 1 and 2 compared to point 3 (\(p\) = 0.002). Differences were also found in desaturation between point 1 (\(p\) < 0.001) and point 2 (\(p\) < 0.001) compared to point 3. The resaturation differences were observed between point 1 (\(p\) < 0.001) and point 2 (\(p\) < 0.001) compared to point 3. Concerning reoxygenation kinetics, differences were found at baseline (Y0) between point 1 and point 3 (\(p\) = 0.042). In amplitude, differences were observed between point 1 (\(p\) < 0.001) and point 2 (\(p\) < 0.001) compared to point 3. The Tau was lower at point 3 compared to point 1 (\(p\) = 0.030) and point 2 (\(p\) = 0.004). Similarly, MRT was longer at point 1 (\(p\) = 0.030) and point 2 (\(p\) = 0.004) compared to point 3. Table 2 shows that participants in point 3 presented lower interval R-R (\(p\) = 0.025), higher Mean HR (\(p\) = 0.013), and higher SNS Index values (\(p\) = 0.033). For the other variables, no differences were observed between conditions. VAS pain showed differences between point 1 (\(p\) < 0.001) and point 2 (\(p\) < 0.001) compared to point 3. Figure 3 presents probability plots based on the percentage of prediction and standardized residuals. The regression model included the following variables: (a) desaturation, \begin{table}
\begin{tabular}{c c c c c c c c c c} \hline \hline \multirow{2}{*}{**Descriptives**} & \multicolumn{2}{c}{**Point 1**} & \multicolumn{2}{c}{**Point 2**} & \multicolumn{2}{c}{**Point 3**} & \multirow{2}{*}{**F**} & \multirow{2}{*}{\(p\)} & \multirow{2}{*}{\(\mathbf{n^{2}p}\)} \\ \cline{3-3} \cline{5-10}  & & & & & & & & & & \\ \cline{3-3} \cline{5-10}  & Initial Occlusion & 70.5 & 6.9 & 72.8 & 9.2 & 77.5 & 5.0 & 1.88 & 0.177 & 0.152 \\ variables & Final Occlusion & 31.7 & 9.3 & 32.3 & 8.1 & 17.4 & 7.2 & 8.26 & 0.002 & 0.440 \\  & Recovery & 77.4 & 5.2 & 78.1 & 8.2 & 81.6 & 3.7 & 1.11 & 0.348 & 0.096 \\  & Occlusion & & & & & & & & & \\ \hline \multirow{3}{*}{\(\text{SmO}_{2}\) dynamics} & Desaturation & 38.8 & 6.2 & 40.5 & 6.2 & 60.0 & 8.4 & 22.4 & \textless{}0.001 & 0.681 \\  & Resaturation & 45.7 & 7.3 & 45.8 & 8.4 & 64.1 & 9.5 & 12.5 & \textless{}0.001 & 0.544 \\  & Hyperemia & 6.9 & 5.9 & 5.3 & 5.0 & 4.1 & 4.4 & 0.554 & 0.583 & 0.050 \\ \hline \multirow{3}{*}{
\begin{tabular}{c} Reoxygenation kinetics \\ \end{tabular} } & Baseline (Y0) & 6.8 & 1.4 & 6.4 & 1.1 & 5.2 & 0.6 & 3.99 & 0.034 & 0.275 \\  & Amplitude & 3.4 & 0.7 & 3.5 & 1.1 & 6.0 & 0.8 & 22.3 & \textless{}0.001 & 0.680 \\ \cline{1-1}  & Time Delay & 2.7 & 0.6 & 2.6 & 0.6 & 4.8 & 0.6 & 0.516 & 0.604 & 0.047 \\ \cline{1-1}  & Tau & 35.9 & 14.5 & 41.3 & 13.5 & 19.0 & 5.4 & 7.58 & 0.003 & 0.419 \\ \cline{1-1}  & MRT & 37.4 & 10.3 & 32.6 & 15.2 & 21.8 & 8.2 & 7.60 & 0.033 & 0.420 \\ \hline \hline \end{tabular} Note. \(p\)-value < 0.05 statistically significant. Effects size: Small \(\leq\) 0.01, medium \(\geq\) 0.059, and large: \(>\)0.138. Point 1 = one day before without fatigue; point 2 = without fatigue, and point 3 = with fatigue conditions. Tau = Constant time and MRT = Mean Response Time.  
\end{table} 
Table 1: Assessment of resting muscle oxygen consumption during vascular occlusion test under fatigue and non-fatigue conditions.